|
|
Volumn 65, Issue 1, 2003, Pages 1-2
|
|
Introduction to special issue: Targeted toxins for glioma therapy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CYTOTOXIN;
DIPHTHERIA TOXIN 389 EPIDERMAL GROWTH FACTOR FUSION PROTEIN;
DIPHTHERIA TOXIN 390 INTERLEUKIN 13 FUSION PROTEIN;
HYBRID PROTEIN;
HYBRID PROTEIN TF CRM107;
HYBRID PROTEIN TP 38;
IMMUNOTOXIN;
INTERLEUKIN 13 PSEUDOMONAS EXOTOXIN 38QQR;
INTERLEUKIN 4 [38-37] PSEUDOMONAS EXOTOXIN 38KDEL;
MONOCLONAL ANTIBODY TO LEWIS Y ANTIGEN CONJUGATED TO DOXORUBICIN;
TOXIN;
UNCLASSIFIED DRUG;
UROKINASE DIPHTHERIA TOXIN FUSION PROTEIN;
ANTINEOPLASTIC ACTIVITY;
BLOOD BRAIN BARRIER;
CANCER IMMUNOTHERAPY;
CANCER INHIBITION;
CANCER MORTALITY;
CANCER SURVIVAL;
CANCER THERAPY;
CENTRAL NERVOUS SYSTEM TUMOR;
CLINICAL TRIAL;
DRUG CYTOTOXICITY;
DRUG DISTRIBUTION;
DRUG EFFICACY;
DRUG TARGETING;
DRUG TUMOR LEVEL;
EDITORIAL;
GENE OVEREXPRESSION;
GENE THERAPY;
GLIOBLASTOMA;
GLIOMA;
HUMAN;
MOLECULAR BIOLOGY;
NEUROSURGERY;
NONHUMAN;
PROTEIN EXPRESSION;
RECURRENT CANCER;
UNITED STATES;
ANIMALS;
CENTRAL NERVOUS SYSTEM NEOPLASMS;
GLIOMA;
HUMANS;
TOXINS, BIOLOGICAL;
|
|
EID: 0344013613
PISSN: 0167594X
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1026258013992 Document Type: Editorial |
|
Times cited : (5)
|
|
References (0)
|
